Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Effect of Subanesthetic Doses of Nalbuphine Combined With Remimazolam in Patients Undergoing Arthroscopic Knee Surgery for Knee Joint Injuries

NCT07838948 is registered in ClinicalTrials.gov with Wuhan Fourth Hospital as lead sponsor.

NCT NCT07838948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07838948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Effect of Subanesthetic Doses of Nalbuphine Combined With Remimazolam in Patients Undergoing Arthroscopic Knee Surgery for Knee Joint Injuries
Lead sponsor
Wuhan Fourth Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 10, 2025
Completion date
October 2, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee injuries